544 related articles for article (PubMed ID: 24482244)
1. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
[TBL] [Abstract][Full Text] [Related]
2. [Update on current care guidelines: oral cancer].
Duodecim; 2012; 128(7):770-1. PubMed ID: 22612027
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
5. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
6. Oral leukoplakia and oral cavity squamous cell carcinoma.
Bewley AF; Farwell DG
Clin Dermatol; 2017; 35(5):461-467. PubMed ID: 28916027
[TBL] [Abstract][Full Text] [Related]
7. Oral potentially malignant disorders in a large dental population.
Villa A; Gohel A
J Appl Oral Sci; 2014; 22(6):473-6. PubMed ID: 25591015
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.
Nagi R; Reddy-Kantharaj YB; Rakesh N; Janardhan-Reddy S; Sahu S
Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e447-55. PubMed ID: 26946209
[TBL] [Abstract][Full Text] [Related]
9. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW
Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420
[TBL] [Abstract][Full Text] [Related]
10. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
11. Oral premalignancy: the roles of early detection and chemoprevention.
Foy JP; Bertolus C; William WN; Saintigny P
Otolaryngol Clin North Am; 2013 Aug; 46(4):579-97. PubMed ID: 23910471
[TBL] [Abstract][Full Text] [Related]
12. Oral cancer: leukoplakia, premalignancy, and squamous cell carcinoma.
Rhodus NL; Kerr AR; Patel K
Dent Clin North Am; 2014 Apr; 58(2):315-40. PubMed ID: 24655525
[No Abstract] [Full Text] [Related]
13. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
15. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of premalignant oral lesions.
Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
[TBL] [Abstract][Full Text] [Related]
18. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
19. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.
Yap T; Pruthi N; Seers C; Belobrov S; McCullough M; Celentano A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
